BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, November 29, 2024
See today's BioWorld Asia
Home
» Mabspace moving to clinic with Lilly-backed $15M series A round
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Mabspace moving to clinic with Lilly-backed $15M series A round
Nov. 4, 2015
By
Cornelia Zou
No Comments
HONG KONG – Start-up antibody-focused Mabspace Biosciences Co. Ltd. has secured $15 million in series A financing with Lilly Asia Ventures to help move two of its cancer candidates into clinical studies and further its antibody pipeline.
BioWorld Asia
